In addiction research, we could use behavioral neuroscience approaches to understand clear connections between behavioral outcomes and drug treatments
There is currently legislation on the table to authorize Medicare to cover obesity treatments
They have a BMI of 32, they can do everything they want, they're muscular, and you're saying I have a disease of obesity
Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,002 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits
With a few simple habits and the right medical guidance, you can feel better, avoid discomfort, and stay more consistent with your weight loss plan this summer
The treatments today are as ineffective as they will ever be, looking ahead: Weight loss efficacy is increasing from 15% to 20% to 25% to 30% The label is expanding from Diabetes to Obesity to Heart Disease and likely Kidney Disease and Sleep Apnea
